COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 208 filers reported holding COHERUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,021,000 | -39.3% | 1,667,123 | -54.3% | 0.46% | -43.8% |
| Q2 2022 | $26,393,000 | -56.5% | 3,645,471 | -22.4% | 0.83% | -31.9% |
| Q1 2022 | $60,623,000 | -64.9% | 4,695,848 | -56.6% | 1.21% | -8.8% |
| Q4 2021 | $172,616,000 | +124.7% | 10,815,596 | +126.3% | 1.33% | +19.3% |
| Q3 2021 | $76,805,000 | -40.9% | 4,779,387 | -49.1% | 1.12% | +32.2% |
| Q2 2021 | $129,936,000 | +89.3% | 9,395,224 | +100.0% | 0.84% | -2.8% |
| Q1 2021 | $68,632,000 | -15.5% | 4,697,612 | +0.6% | 0.87% | -0.3% |
| Q4 2020 | $81,197,000 | +21.7% | 4,671,836 | +28.5% | 0.87% | -10.6% |
| Q3 2020 | $66,693,000 | +584.8% | 3,636,485 | +566.9% | 0.97% | +516.5% |
| Q2 2020 | $9,739,000 | +30.3% | 545,285 | +110.8% | 0.16% | -64.9% |
| Q2 2015 | $7,477,000 | +186.7% | 258,716 | +203.3% | 0.45% | +121.7% |
| Q1 2015 | $2,608,000 | -63.5% | 85,288 | -80.5% | 0.20% | -66.1% |
| Q4 2014 | $7,148,000 | – | 438,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 660,000 | $9,643,000 | 7.68% |
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $9,497,000 | 2.67% |
| Sio Capital Management, LLC | 847,862 | $12,387,000 | 2.51% |
| Redwood Investments, LLC | 761,252 | $11,122,000 | 0.98% |
| Perceptive Advisors | 4,697,612 | $68,632,000 | 0.87% |
| CM Management, LLC | 75,000 | $1,096,000 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $1,461,000 | 0.80% |
| Bridge City Capital, LLC | 164,029 | $2,396,000 | 0.79% |
| Prairiewood Capital, LLC | 52,292 | $764,000 | 0.70% |
| Aristotle Capital Boston, LLC | 2,101,687 | $30,706,000 | 0.68% |